Clinical Trial Update: Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of T-1101 tosylate capsules for advanced solid tumors is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• T-1101 tosylate (T-1101 tosylate)

Snippet

Sponsor: Taivex Therapeutics Corporation | Conditions: Advanced Refractory Solid Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING